Researchers demonstrated that axon regenerative capacity can be boosted with the right stimulants on neuronal activity through either an optogenetic or a chemogenetic approach.

They found that overexpression of a photopigment, melanopsin, in retinas could enhance neuronal firing of retinal ganglion cells (RGCs) and promote axonal regeneration after optic nerve crush by activating mammalian target of rapamycin (mTOR) signaling. Axon regeneration can also be promoted by activating Gq signaling in RGCs through Designer Receptor Exclusively Activated by Designer Drugs (DREADD), wildly adopted as a tool to increase neuronal activity.

The findings were published in the journal PNAS. The research team started the investigation on mice by overexpressing melanopsin in RGCs using adeno-associated virus (AAV) to determine whether melanopsin could promote axonal regeneration. Axonal regeneration was evident after two weeks, and the effect was found to be stimulated by light and neuronal firing, which enhanced and maintained mTOR signaling.

To mimic the downstream pathway of melanopsin and also stimulate neuronal activity through a different method, the researchers took a chemogenetic approach by injecting AAVs expressing DREADD-Gq into the eyes of the mice. A significant increase in axonal growth was detected as well after daily administration of a synthetic agonist clozapine-n-oxide.

"Our results show that melanopsin boosts axon regeneration by enhancing mTORC1 in a neuronal activity-dependent manner," author said. "Melanopsin activates Gq/11 signaling that subsequently increases neuronal activity and calcium influx to a degree that may be necessary to sustain long-term mTOR activation in RGCs."

http://www.pnas.org/content/early/2016/01/29/1523645113